Addition of 10-Day Decitabine to Fludarabine/Total Body Irradiation Conditioning is Feasible and Induces Tumor-Associated Antigen-Specific T Cell Responses

Author(s):
Cruijsen, M.; Hobo, W.; Velden, W.J.F.M. van der; Bremmers, M.E.J.; Woestenenk, R.; Bar, B.; Falkenburg, J.H.F.; Kester, M.; Schaap, N.P.M.; Jansen, J.; Blijlevens, N.N.M.; Dolstra, H.; Huls, G.
Published
2016
Publication type
Article / Letter to editor
DecitabineHypomethylating agentsNonmyeloablative conditioningHematopoietic cell transplantationPoor-risk acute myelogenous leukemia/myelodysplastic syndrome
Date issued
2016-06-30
Language
English
Is part of
Biology of Blood and Marrow Transplantation (2016), Vol. 22, no. 6, p. 1000-1008
hdl
1887/113810
doi
10.1016/j.bbmt.2016.02.003